Abstract:Objective- Despite the high clinical relevance of thrombolysis, models for its study in human flowing blood are lacking. Our objective was to develop a microfluidic model for comparative evaluation of thrombolytic therapeutic strategies. Approach and Results- Citrated human blood was supplemented with 3,3'-dihexyloxacarbocyanine iodide and Alexa Fluor 647 fibrinogen conjugate, recalcified, and perfused for 3 to 4 minutes at venous or arterial wall shear rate in microfluidic flow chambers coated with collagen and tissue factor to generate nonocclusive fluorescent thrombi. A second perfusion was performed for 10 minutes with rhodamine-6G-labeled citrated whole blood, supplemented or not with r-tPA (recombinant tissue-type plasminogen activator), fluorescein isothiocyanate-conjugated r-tPA, and Alexa Fluor 568 plasminogen conjugate. Plasminogen and r-tPA bound to preformed thrombi and r-tPA caused a concentration-dependent decrease in thrombus fibrin content (up to 50% reduction at 15 μg/mL r-tPA) as assessed by fluorescence microscopy. Fibrinolysis was confirmed by measurement of D-dimers in the output flow. Remarkably, despite ongoing fibrinolysis, new platelets continued to be recruited to the thrombus under lysis. Under the arterial condition, combining r-tPA with hirudin enhanced fibrinolysis but did not prevent the recruitment of new platelets, which was, however, prevented by antiplatelet agents (ticagrelor or the GPVI [glycoprotein VI]-blocking antigen-binding fragment 9O12). Conclusions- Our microfluidic thrombolysis model is suitable for studying thrombolysis and testing the efficacy of drugs used in combination with r-tPA. Real-time analysis of fibrin and platelets during r-tPA-mediated fibrinolysis at arterial or venous flow conditions showed that platelets continue to accumulate during fibrinolysis. Such platelet accumulation may impair r-tPA-mediated recanalization.

Menstrually related migraine: breaking the cycle in your clinical practice.

Murine Models of Vascular Endothelial Injury: Techniques and Pathophysiology

Microfluidic-based <i>in vitro</i> thrombosis model for studying microplastics toxicity

THE MODEL OF INTRAMICROVASCULAR THROMBUS INDUCED BY FLUORESCEIN SODIUM AND ANALYSIS WITH COMPUTOR

Longitudinal in Vivo Intrinsic Optical Imaging of Cortical Blood Perfusion and Tissue Damage in Focal Photothrombosis Stroke Model.

Investigating clot-flow interactions by integrating intravital imaging with in silico modeling for analysis of flow, transport, and hemodynamic forces

Mouse laser injury models: variations on a theme

Structural dynamics of second vs . first rank cities : similar laws , different nature

Zebrafish thrombosis models according to the location of thrombus formation

Stopped Flow Fluorescence Energy Transfer Measurement of the Rate Constants Describing the Reversible Formation and the Irreversible Rearrangement of the Elastase-α1-Proteinase Inhibitor Complex*

Diving head-first into brain intravital microscopy

A Clot-Homing Near-Infrared Probe for In Vivo Imaging of Murine Thromboembolic Models

Abstract 10086: Cardiac Intravital Microscopy Enables Quantitative Mapping of Capillary-Level Blood Flow in the Murine Heart

Endogenous opiates and behavior: 2006

Microfluidic Modeling of Thrombolysis.

Localization of 111Indium‐labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response

Application of "in Vivo Cryotechnique" to Morphological and Immunohistochemical Analyses of Living Mouse Subepicardial Microcirculation under Various Pathological Conditions

Controlling the Volume of the Focal Cerebral Ischemic Lesion through Photothrombosis

Three-Dimensional Reconstruction of Thrombus Formation During Photochemically Induced Arterial and Venous Thrombosis

Chapter 11. Intravital microscopic investigation of leukocyte interactions with the blood vessel wall

Endovascular ischemic stroke models of adult rhesus monkeys: a comparison of two endovascular methods